X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (514) 514
male (436) 436
middle aged (318) 318
oncology (287) 287
adult (276) 276
index medicus (239) 239
aged (223) 223
female (190) 190
cancer (164) 164
adolescent (103) 103
urology & nephrology (103) 103
chemotherapy (100) 100
radiotherapy (95) 95
quality of life (94) 94
survivors (94) 94
risk factors (91) 91
surveys and questionnaires (87) 87
testicular cancer (81) 81
quality-of-life (77) 77
prognosis (74) 74
prostate cancer (74) 74
follow-up studies (73) 73
research (69) 69
aged, 80 and over (67) 67
norway (64) 64
combined modality therapy (60) 60
time factors (60) 60
testicular neoplasms - drug therapy (55) 55
young adult (54) 54
neoplasm staging (53) 53
cross-sectional studies (52) 52
cancer survivors (51) 51
norway - epidemiology (51) 51
risk (50) 50
testicular neoplasms - therapy (49) 49
antineoplastic combined chemotherapy protocols - therapeutic use (48) 48
testicular neoplasms - pathology (48) 48
breast-cancer (47) 47
oncology, experimental (46) 46
treatment outcome (45) 45
men (43) 43
testicular neoplasms - genetics (43) 43
case-control studies (42) 42
analysis (41) 41
care and treatment (41) 41
therapy (41) 41
long-term survivors (40) 40
prevalence (40) 40
survival rate (40) 40
retrospective studies (39) 39
antineoplastic agents - adverse effects (37) 37
hematology, oncology and palliative medicine (36) 36
prostatic neoplasms - radiotherapy (36) 36
survival (36) 36
health aspects (35) 35
medicine & public health (35) 35
prostatic neoplasms - pathology (35) 35
depression (34) 34
germ-cell tumors (34) 34
mortality (34) 34
prostatic neoplasms - therapy (34) 34
radical prostatectomy (34) 34
testicular neoplasms - surgery (34) 34
diagnosis (32) 32
follow-up (32) 32
health (32) 32
prostatic neoplasms - drug therapy (32) 32
survivors - psychology (32) 32
testis (32) 32
carcinoma (31) 31
population (30) 30
radiology, nuclear medicine & medical imaging (30) 30
registries (30) 30
cisplatin - administration & dosage (29) 29
multivariate analysis (29) 29
prostatic neoplasms - mortality (29) 29
survival analysis (29) 29
survivors - statistics & numerical data (29) 29
fatigue (28) 28
impact (28) 28
urology (28) 28
breast cancer (27) 27
orchiectomy (27) 27
antineoplastic combined chemotherapy protocols - adverse effects (26) 26
anxiety (25) 25
disease-free survival (25) 25
morbidity (25) 25
prostatic neoplasms - surgery (25) 25
radiation-therapy (25) 25
seminoma (25) 25
surgery (25) 25
survivor (25) 25
testicular neoplasms - mortality (25) 25
incidence (24) 24
antineoplastic agents - therapeutic use (23) 23
cisplatin - adverse effects (23) 23
medicin och hälsovetenskap (23) 23
radiotherapy - adverse effects (23) 23
risk assessment (23) 23
testicular neoplasms - psychology (23) 23
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 738 - 746
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9660, pp. 301 - 308
Journal Article
Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 76 - 86
Summary Background Patients with muscle-invasive urothelial carcinoma of the bladder have poor survival after cystectomy. The EORTC 30994 trial aimed to... 
Hematology, Oncology and Palliative Medicine | ADJUVANT CHEMOTHERAPY | PLUS CISPLATIN | METAANALYSIS | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | DOXORUBICIN | METHOTREXATE | VINBLASTINE | CANCER | GEMCITABINE | Lymph Node Excision | Cystectomy - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Male | Vinblastine - administration & dosage | Cystectomy - adverse effects | Urothelium - pathology | Cisplatin - administration & dosage | Time Factors | Urinary Bladder Neoplasms - pathology | Female | Chemotherapy, Adjuvant | Carcinoma - pathology | Doxorubicin - administration & dosage | Carcinoma - drug therapy | Urinary Bladder Neoplasms - mortality | Drug Administration Schedule | Time-to-Treatment | Carcinoma - surgery | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Methotrexate - administration & dosage | Urothelium - surgery | Neoplasm Staging | Urothelium - drug effects | Deoxycytidine - analogs & derivatives | Care and treatment | Chemotherapy | Carcinoma | Hospitals | Cancer
Journal Article
Nature Genetics, ISSN 1061-4036, 06/2013, Volume 45, Issue 6, pp. 680 - 685
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 12/2009, Volume 101, Issue 24, pp. 1682 - 1695
Background Sensory neuropathy (paresthesias), tinnitus, hearing impairment, and Raynaud phenomena are side effects of cisplatin-based chemotherapy used to... 
CISPLATIN-BASED CHEMOTHERAPY | HEARING-LOSS | RISK-FACTORS | ONCOLOGY | EUROPEAN CONSENSUS CONFERENCE | CLINICAL STAGE-I | INDUCED PERIPHERAL NEUROPATHY | COMBINATION CHEMOTHERAPY | QUALITY-OF-LIFE | GERM-CELL-CANCER | MEDICAL-RESEARCH-COUNCIL | Paresthesia - epidemiology | Sensation Disorders - epidemiology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prevalence | Audiometry | Follow-Up Studies | Humans | Middle Aged | Survivors - statistics & numerical data | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cisplatin - administration & dosage | Raynaud Disease - epidemiology | Tinnitus - chemically induced | Adult | Surveys and Questionnaires | Odds Ratio | Paresthesia - chemically induced | Hearing Loss - chemically induced | Severity of Illness Index | Sensation Disorders - chemically induced | Cross-Sectional Studies | Drug Administration Schedule | Seminoma - drug therapy | Hearing Loss - epidemiology | Regression Analysis | Tinnitus - epidemiology | Testicular Neoplasms - drug therapy | Norway - epidemiology | Cisplatin - adverse effects | Raynaud Disease - chemically induced | Aged | Research Design | Cancer survivors | Complications and side effects | Prognosis | Demographic aspects | Raynaud's disease | Testicular cancer | Peripheral nerve diseases | Risk factors | Diseases | Index Medicus
Journal Article
Quality of Life Research, ISSN 0962-9343, 5/2018, Volume 27, Issue 5, pp. 1201 - 1212
Journal Article
Journal Article
Journal Article
Journal Article